Clinical Trial

A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-19; most recent amendment 2026-02-04.
Status change: Not Yet Recruiting → Recruiting 2026-02-04
Trial Details
NCT Number NCT07370584
Lead Sponsor iVeena Delivery Systems, Inc.
Collaborators: Lexitas Pharma Services, Inc.
Conditions Safety Study
Enrollment 36 participants
Start Date 2026-02-04
Primary Completion 2026-05 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-05